Search Results - Stephen Grupp
- Showing 1 - 5 results of 5
-
1
-
2
-
3
Risk factors and timing of relapse after allogeneic transplantation in pediatric ALL: for whom and when should interventions be tested? by Mike A. Pulsipher, Bryan Langholz, Donna A. Wall, Kirk R. Schultz, Nancy Bunin, W L Carroll, Elizabeth A. Raetz, Sharon L. Gardner, Rakesh K. Goyal, Julie M. Gastier‐Foster, Michael J. Borowitz, David T. Teachey, Stephen Grupp
Published 2015Artigo -
4
Biomarkers in newly diagnosed pediatric-extensive chronic graft-versus-host disease: a report from the Children's Oncology Group by Hisaki Fujii, Geoff D.E. Cuvelier, Kevin She, Soudabeh Aslanian, Hiromi Shimizu, Amina Kariminia, Mark Krailo, Zhengjia Chen, Rob McMaster, Axel Bergman, Frederick D. Goldman, Stephen Grupp, Donna A. Wall, Andrew L. Gilman, Kirk R. Schultz
Published 2007Artigo -
5
Persistence of long-lived plasma cells and humoral immunity in individuals responding to CD19-directed CAR T-cell therapy by Vijay Bhoj, Dimitrios C. Arhontoulis, Gerald Wertheim, James Capobianchi, Colleen Callahan, Christoph T. Ellebrecht, Amrom E. Obstfeld, Simon F. Lacey, J. Joseph Melenhorst, Farzana Nazimuddin, Wei‐Ting Hwang, Shannon L. Maude, Mariusz A. Wasik, Adam Bagg, Stephen J. Schuster, Michael D. Feldman, David L. Porter, Stephen Grupp, Carl H. June, Michael C. Milone
Published 2016Artigo
Search Tools:
Related Subjects
Medicine
Biology
Immunology
Internal medicine
Biochemistry
CD19
Gastroenterology
Genetics
Immune system
Leukemia
Oncology
Transplantation
Adoptive cell transfer
Antibody
Antigen
Antigen-presenting cell
Biomarker
Bystander effect
CD28
CD8
Cancer
Cancer research
Cardiology
Cardiomyopathy
Cell culture
Chemistry
Chimeric antigen receptor
Clinical endpoint
Clinical trial
Concomitant